- Home
- GENK vs PMN Comparison
GENK vs PMN Comparison
Compare GENK & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GENK
- PMN
- Stock Information
- Founded
- GENK 2011
- PMN 2004
- Country
- GENK United States
- PMN Canada
- Employees
- GENK N/A
- PMN N/A
- Industry
- GENK Restaurants
- PMN Pharmaceuticals and Biotechnology
- Sector
- GENK Consumer Discretionary
- PMN Health Care
- Exchange
- GENK Nasdaq
- PMN Nasdaq
- Market Cap
- GENK 16.3M
- PMN 22.3M
- IPO Year
- GENK 2023
- PMN N/A
- Fundamental
- Price
- GENK $3.07
- PMN $0.42
- Analyst Decision
- GENK Strong Buy
- PMN Strong Buy
- Analyst Count
- GENK 2
- PMN 3
- Target Price
- GENK $7.00
- PMN $4.33
- AVG Volume (30 Days)
- GENK 47.0K
- PMN 3.1M
- Earning Date
- GENK 11-11-2025
- PMN 11-13-2025
- Dividend Yield
- GENK 3.77%
- PMN N/A
- EPS Growth
- GENK N/A
- PMN N/A
- EPS
- GENK N/A
- PMN N/A
- Revenue
- GENK $216,137,000.00
- PMN N/A
- Revenue This Year
- GENK $12.35
- PMN N/A
- Revenue Next Year
- GENK $14.62
- PMN N/A
- P/E Ratio
- GENK N/A
- PMN N/A
- Revenue Growth
- GENK 10.67
- PMN N/A
- 52 Week Low
- GENK $3.05
- PMN $0.38
- 52 Week High
- GENK $10.33
- PMN $1.59
- Technical
- Relative Strength Index (RSI)
- GENK 36.81
- PMN 37.32
- Support Level
- GENK $3.11
- PMN $0.39
- Resistance Level
- GENK $3.39
- PMN $0.45
- Average True Range (ATR)
- GENK 0.15
- PMN 0.04
- MACD
- GENK 0.02
- PMN -0.01
- Stochastic Oscillator
- GENK 5.13
- PMN 16.71
About GENK GEN Restaurant Group Inc.
GEN Restaurant Group Inc operates an Asian casual dining restaurant chain, offering an extensive menu of traditional Korean and Korean-American food, including high-quality meats, poultry, seafood, and mixed vegetables. It operates 43 Gen Korean BBQ restaurants in the United States.
About PMN ProMIS Neurosciences Inc. (ON)
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.